Skip to the content
Please enable JavaScript in your browser to complete this form.
Pre-meeting Survey
1. Please select your speciality:
*
Oncologist
Pulmonologist
Surgeon
2. Would you consider using adjuvant therapy for early-stage NSCLC?
*
Yes
No
Do you have experience initiating adjuvant therapy with EGFR-TKI?
*
Yes
No
How many patients have you initiated adjuvant therapy with EGFR-TKI in the last 3 months?
*
<5 patients
6–20 patients
≥21 patients
Unsure
Of the patients who underwent complete tumour resection surgery in the last 3 months, how many were referred to oncologists for adjuvant therapy consultation or treatment?
*
<5 patients
6–20 patients
≥21 patients
Unsure
Do you have experience using IO as adjuvant therapy for early-stage NSCLC?
*
Yes
No
How many patients do you typically treat with IO as an adjuvant therapy in a year?
*
<5 patients
6–20 patients
>21 patients
Unsure
3. Would you consider using neoadjuvant therapy for early-stage NSCLC?
*
Yes
No
Do you have experience using IO as neoadjuvant therapy?
*
Yes
No
How many patients do you typically treat with IO as a neoadjuvant therapy in a year?
*
<5 patients
6–20 patients
>21 patients
Unsure
Submit
HK-9296 08/2023